RNXT RenovoRx, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$1,58
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,70mínimo 52 semanas
$2,59máximo 52 semanas
Capitalización Bursátil (MRQ)
$71M
P/E (TTM)
-5.1
BPA (TTM)
$-0.31
Ingresos (TTM)
$2M
tus insignias
Rango 52S
$1–$3
Calificación del Analista
BUY
Precio Objetivo
$7
P/E
-5.1
ROE
-125.2%
Margen de Beneficio Neto
-621.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
RNXT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.58
Capitalización Bursátil (MRQ)
$71M
P/E (TTM)
-5.1
BPA (TTM)
$-0.31
Ingresos (TTM)
$2M
ROE (TTM)
-125.2%
Rango 52S
$1–$3
RNXT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$1M2024-12-31 → 2025-12-31
BPA$-0.322022-12-31 → 2025-12-31
Flujo de caja libre·2024-12-31 → 2024-12-31
Margen neto-621.7%2021-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | RNXT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -5.1promedio 5A ≈-2.6 | ≈-2.6 | · | · | |
| P/S (TTM) | 36.1 | · | 233.7 | Infravalorado | |
| P/C (MRQ) | 7.9promedio 5A ≈1.3 | ≈1.3 | 2.9 | Sobrevalorado | |
| Precio / FCF (TTM) | -6.0 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -6.0promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 5.7promedio 5A ≈5.4 | ≈5.4 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | RNXT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Bruto (TTM) | 84.4% | · | · | · | |
| Margen Operativo (TTM) | -685.2% | · | -2921.7% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | -621.7% | · | -1556.0% | De primer nivel | |
| ROA (TTM) | -97.8%promedio 5A ≈-142.9% | ≈-142.9% | -69.9% | Débil | |
| ROE (TTM) | -125.2%promedio 5A ≈88.6% | ≈88.6% | -65.7% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | RNXT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 5.7 | · | 5.7 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | RNXT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 2511.6% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | RNXT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue / Employee (Ingresos / Empleado) | ≈$66.1K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
2.8%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-0.05 | $-0.07 | 32.4% |
| 31 de marzo de 2026 | May 14, 2026 | $-0.09 | $-0.08 | -10.3% |
| 31 de diciembre de 2025 | $-0.08 | $-0.08 | 2.0% | |
| 30 de septiembre de 2025 | $-0.08 | $-0.08 | 2.0% | |
| 30 de junio de 2025 | $-0.08 | $-0.09 | 7.7% | |
| 31 de marzo de 2025 | $-0.08 | $-0.08 | 2.0% | |
| 31 de diciembre de 2024 | $-0.13 | $-0.11 | -15.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $1M | $43.0K | |
| Cost of Revenue | $327.0K | $0 | |
| Gross Profit | $796.0K | $43.0K | |
| R&D Expense | $6M | $6M | |
| SG&A Expense | $7M | $5M | |
| Operating Expenses | $13M | $11M | |
| Operating Income | $-13M | $-11M | |
| Other Non-op | $1M | $2M | |
| Pretax Income | $-11M | $-9M | |
| Income Tax | $2.0K | · | |
| Net Income | $-11M | $-9M | |
| EPS (Basic) | $-0.32 | $-0.40 | |
| EPS (Diluted) | $-0.32 | $-0.40 | |
| Shares (Basic) | 35,333,127 | 22,271,163 | |
| Shares (Diluted) | 35,333,127 | 22,271,163 | |
| EBITDA | · | $-11M |
Balance general
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $7M | $7M | |
| Receivables | $139.0K | $43.0K | |
| Inventory | $189.0K | $0 | |
| Prepaid Expense | $324.0K | $328.0K | |
| Other Current Assets | $217.0K | $303.0K | |
| Current Assets | $8M | $8M | |
| PP&E (Net) | $12.0K | $12.0K | |
| PP&E (Gross) | · | $12.0K | |
| Other Non-current Assets | $0 | · | |
| Total Assets | $8M | $8M | |
| Accounts Payable | $799.0K | $586.0K | |
| Accrued Liabilities | $1M | $1M | |
| Current Liabilities | $2M | $2M | |
| Capital Leases | $107.0K | $212.0K | |
| Total Liabilities | $3M | $4M | |
| Common Stock | $4.0K | $2.0K | |
| Retained Earnings | $-61M | $-50M | |
| Stockholders' Equity | $5M | $4M | |
| Liabilities + Equity | $8M | $8M | |
| Shares Outstanding | 36,613,916 | 24,034,672 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $0 | |
| Stock-based Comp | $1M | $1M | |
| Deferred Tax | $0 | $0 | |
| Operating Cash Flow | $-11M | $-9M | |
| CapEx | $2.0K | $12.0K | |
| Investing Cash Flow | $-2.0K | $-12.0K | |
| Stock Issued | $12M | $17M | |
| Net Stock Activity | · | $15M | |
| Financing Cash Flow | $11M | $15M | |
| Net Change in Cash | $-130.0K | $6M | |
| Taxes Paid | $1.0K | $2.0K | |
| Free Cash Flow | · | $-9M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | · | 100.0% | |
| Operating Margin | · | -25511.6% | |
| Net Margin | · | -20497.7% | |
| EBITDA Margin | · | -25511.6% | |
| ROA | · | -183.9% | |
| ROE | · | -152.6% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | · | 4.1 | |
| Quick Ratio | · | 3.8 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | · | 0.0 | |
| Receivables Turnover | · | 2.0 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | · | $0.19 | |
| Revenue / Share | · | $0.00 | |
| Cash Flow / Share | · | $-0.41 | |
| Cash / Share | · | $0.30 | |
| EPS (TTM) | $-0.32 | $-0.40 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 2511.6% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $1M | $43.0K | |
| Net Income TTM | $-11M | $-9M | |
| Market Cap | · | $31M | |
| P/E | -2.6 | -3.2 | |
| P/S | · | 721.0 | |
| P/B | · | 6.9 | |
| P / Tangible Book | 5.7 | 6.9 | |
| P / Cash Flow | · | -3.4 | |
| P / FCF | · | -3.4 | |
| Earnings Yield | -38.1% | -31.0% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $909.0K | $563.0K | $238.0K | $266.0K | $422.0K | $197.0K | |
| Cost of Revenue | $143.0K | $84.0K | $28.0K | $53.0K | $152.0K | $94.0K | |
| Gross Profit | $766.0K | $479.0K | $210.0K | $213.0K | $270.0K | $103.0K | |
| R&D Expense | $1M | $1M | $2M | $2M | $1M | $2M | |
| SG&A Expense | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Income | $-3M | $-3M | $-4M | $-3M | $-3M | $-3M | |
| Other Non-op | $438.0K | $-52.0K | $581.0K | $288.0K | $-217.0K | $690.0K | |
| Income Tax | $0 | $0 | $2.0K | $0 | $0 | $0 | |
| Net Income | $-3M | $-4M | $-3M | $-3M | $-3M | $-2M | |
| EPS (Basic) | $-0.06 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.08 | |
| EPS (Diluted) | $-0.06 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.08 | |
| Shares (Basic) | 47,298,148 | 38,032,421 | · | 36,646,278 | 36,576,567 | 31,395,888 | |
| Shares (Diluted) | 47,298,148 | 38,032,421 | · | 36,646,278 | 36,576,567 | 31,395,888 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-3M | $-3M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $12M | $7M | $10M | $12M | $15M | |
| Receivables | $480.0K | $280.0K | $139.0K | $169.0K | $363.0K | $242.0K | |
| Inventory | $383.0K | $379.0K | $189.0K | $272.0K | · | · | |
| Prepaid Expense | $315.0K | $501.0K | $324.0K | $350.0K | $430.0K | $477.0K | |
| Other Current Assets | $153.0K | $198.0K | $217.0K | $145.0K | $288.0K | $444.0K | |
| Current Assets | $11M | $14M | $8M | $11M | $13M | $16M | |
| PP&E (Net) | $94.0K | $77.0K | $12.0K | $13.0K | $13.0K | $13.0K | |
| PP&E (Gross) | · | · | · | $15.0K | · | · | |
| Accum. Depreciation | · | · | · | $2.0K | · | · | |
| Other Non-current Assets | $200.0K | · | · | · | · | · | |
| Total Assets | $11M | $14M | $8M | $11M | $14M | $16M | |
| Accounts Payable | $866.0K | $1M | $799.0K | $869.0K | $671.0K | $967.0K | |
| Accrued Liabilities | $1M | $801.0K | $1M | $1M | $885.0K | $769.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | $259.0K | $78.0K | $107.0K | $134.0K | $161.0K | $186.0K | |
| Total Liabilities | $2M | $3M | $3M | $3M | $3M | $3M | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-68M | $-65M | $-61M | $-58M | $-56M | $-53M | |
| Stockholders' Equity | $9M | $11M | $5M | $8M | $11M | $13M | |
| Liabilities + Equity | $11M | $14M | $8M | $11M | $14M | $16M | |
| Shares Outstanding | 45,121,982 | 45,052,706 | 36,613,916 | 36,649,916 | 36,645,884 | 36,546,752 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | · | $1.0K | $0 | $1M | $1M | · | |
| Stock-based Comp | $570.0K | $317.0K | $285.0K | $349.0K | $345.0K | $288.0K | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-2M | $-2M | $-3M | |
| CapEx | $71.0K | $0 | $0 | $0 | $0 | $2.0K | |
| Investing Cash Flow | $-71.0K | $0 | $0 | $0 | $0 | $-2.0K | |
| Stock Issued | $0 | $10M | · | · | $0 | $12M | |
| Net Stock Activity | · | $10M | · | · | · | · | |
| Financing Cash Flow | $55.0K | $9M | $0 | $0 | $34.0K | $11M | |
| Net Change in Cash | $-3M | $5M | $-3M | $-2M | $-2M | $7M | |
| Taxes Paid | $1.0K | $0 | $-1.0K | $0 | $1.0K | $1.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-3M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 84.3% | 85.1% | · | 80.1% | 64.0% | 52.3% | |
| Operating Margin | -368.4% | -616.2% | · | -1203.0% | -634.6% | -1578.7% | |
| Net Margin | -320.2% | -625.4% | · | -1094.7% | -686.0% | -1228.4% | |
| EBITDA Margin | -368.4% | -616.2% | · | -1203.0% | -634.6% | -1578.7% | |
| ROA | -23.2% | -23.5% | · | -27.4% | -22.6% | -23.3% | |
| ROE | -29.7% | -28.8% | · | -38.4% | -29.1% | -32.4% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.1 | · | 5.8 | 8.6 | 9.1 | |
| Quick Ratio | 5.3 | 6.6 | · | 5.4 | 8.1 | 8.5 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.7 | 0.4 | · | 0.4 | · | · | |
| Receivables Turnover | 2.2 | 2.2 | · | 3.1 | 2.3 | 1.6 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.20 | $0.25 | · | $0.22 | $0.29 | $0.36 | |
| Revenue / Share | $0.02 | $0.01 | · | $0.01 | $0.01 | $0.01 | |
| Cash Flow / Share | · | $-0.10 | · | · | · | $-0.11 | |
| Cash / Share | $0.21 | $0.27 | · | $0.27 | $0.34 | $0.40 | |
| EPS (TTM) | $-0.31 | $-0.33 | · | $-0.37 | $-0.39 | $-0.41 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $1M | · | · | · | · | |
| Net Income TTM | $-12M | $-12M | · | $-11M | $-11M | $-10M | |
| Market Cap | $44M | $46M | · | $47M | $48M | $36M | |
| P/E | -3.2 | -3.1 | · | -3.4 | -3.4 | -2.4 | |
| P/S | 22.4 | 30.6 | · | · | · | · | |
| P/B | 4.9 | 4.0 | · | 5.8 | 4.5 | 2.8 | |
| P / Tangible Book | 4.9 | 4.0 | · | 5.8 | 4.5 | 2.8 | |
| P / Cash Flow | · | -12.3 | · | · | · | -10.7 | |
| Earnings Yield | -31.6% | -32.7% | · | -29.1% | -29.7% | -41.4% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $1M | $43.0K | · | · | · |
| Margen Bruto % | · | 100.0% | · | · | · |
| Margen Operativo % | · | -25511.6% | · | · | 680.0% |
| Beneficio neto | $-11M | $-9M | $-10M | $-10M | $-6M |
| EPS Diluido | $-0.32 | $-0.40 | $-0.99 | $-1.09 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | · | 4.1 | · | · | 17.4 |
| Ratio Rápido | · | 3.8 | 1.0 | · | 16.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-9M | · | · | · |
Propietarios institucionales (13F) 29 declarantes · $10.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
29
Valor en tenencia
$10.3M
Nuevas posiciones
3
Posiciones cerradas
6
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 3 (-1 vs trimestre anterior) | 6 (+1 vs trimestre anterior) | 8 (-3 vs trimestre anterior) | 6 (+2 vs trimestre anterior) | +633K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| AIGH Capital Management LLC | $4 317 330 | 4 405 439 | 41,72% | Acciones |
| Bleichroeder LP | $1 632 776 | 1 666 098 | 15,78% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 414 867 | 1 443 742 | 13,67% | Acciones |
| VANGUARD GROUP INC | $1 348 267 | 1 605 079 | 13,03% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $415 687 | 424 148 | 4,02% | Acciones |
| Wealthspire Advisors, LLC | $247 475 | 252 525 | 2,39% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $235 523 | 240 330 | 2,28% | Acciones |
| CITADEL ADVISORS LLC | $130 925 | 133 597 | 1,27% | Acciones |
| NORTHERN TRUST CORP | $83 503 | 85 207 | 0,81% | Acciones |
| Chicago Partners Investment Group LLC | $78 918 | 92 356 | 0,76% | Acciones |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $73 104 | 74 596 | 0,71% | Acciones |
| Caprock Group, LLC | $62 661 | 63 940 | 0,61% | Acciones |
| JANE STREET GROUP, LLC | $45 471 | 46 399 | 0,44% | Acciones |
| Kestra Advisory Services, LLC | $34 810 | 35 520 | 0,34% | Acciones |
| TWO SIGMA SECURITIES, LLC | $34 092 | 34 788 | 0,33% | Acciones |
| XTX Topco Ltd | $29 383 | 29 983 | 0,28% | Acciones |
| Clear Creek Financial Management, LLC | $28 477 | 29 058 | 0,28% | Acciones |
| STATE STREET CORP | $25 629 | 26 152 | 0,25% | Acciones |
| UBS Group AG | $20 404 | 20 820 | 0,20% | Acciones |
| HighTower Advisors, LLC | $19 600 | 20 000 | 0,19% | Acciones |
| Cetera Investment Advisers | $18 620 | 19 000 | 0,18% | Acciones |
| Affinity Capital Advisors, LLC | $12 583 | 13 279 | 0,12% | Acciones |
| CAPTRUST FINANCIAL ADVISORS | $12 061 | 12 307 | 0,12% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $11 172 | 11 400 | 0,11% | Acciones |
| MORGAN STANLEY | $6 960 | 7 102 | 0,07% | Acciones |
| Midway Capital Research & Management | $6 174 | 6 300 | 0,06% | Acciones |
| Tower Research Capital LLC (TRC) | $1 138 | 1 161 | 0,01% | Acciones |
| BARCLAYS PLC | $1 128 | 1 151 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $686 | 700 | 0,01% | Acciones |
Informantes de la empresa 11 insiders · 6 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Shaun Bagai | Chief Executive Officer | 3 de abril de 2026 A | 313 357 | 2 | 0 | $8 750 |
| Mark Voll | Chief Financial Officer | 10 de septiembre de 2026 A | 222 380 | 1 | 0 | $19 750 |
| Angela Nelms | Chief Operating Officer | 19 de enero de 2024 A | 1 100 | 0 | 0 | $0 |
| Leesa Gentry | Chief Clinical Officer | 3 de abril de 2026 A | · | 0 | 0 | $0 |
| Ramtin Agah | Chief Medical Officer | 3 de abril de 2026 A | 798 460 | 7 | 0 | $55 994 |
| Ron Kocak | VP, Controller and PAO | 1 de julio de 2025 A | 12 595 | 0 | 0 | $0 |
| Kirsten Angela Macfarlane | Consejero | 1 de octubre de 2026 A | 40 983 | 0 | 0 | $0 |
| Laurence Marton | Consejero | 1 de octubre de 2026 A | 9 720 | 0 | 0 | $0 |
| Robert J. Spiegel | Consejero | 1 de octubre de 2026 A | 40 983 | 0 | 0 | $0 |
| Una S Ryan | Consejero | 1 de octubre de 2026 A | 97 165 | 0 | 0 | $0 |
| David Diamond | Consejero | 1 de octubre de 2023 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
RNXT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 10 analistas
COMPRA
Objetivo mediano
$5.50
+248,1%
2 20,0%
Compra fuerte
7 70,0%
Compra
1 10,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-09-30Objetivo medio $7.12 +350,9%
← Por Debajo de Todos los Objetivos
Precio Actual $1.58
Mín$3.00
Media$7.12
Máx$14.50
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| RNXT | · | -2.6 | 2511.6% | · | · | · |
| GANX | $135M | -5.3 | -60.6% | · | -181.1% | · |
| TENX | $114M | -9.1 | · | · | -52.5% | · |
| ALDX | $312M | -9.2 | · | · | -68.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| RNTX | · | -0.6 | · | · | · | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| XBIT | · | -1.6 | · | · | · | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026